Original language | English (US) |
---|---|
Pages (from-to) | 1405-1409.e1 |
Journal | Journal of Investigative Dermatology |
Volume | 144 |
Issue number | 6 |
DOIs | |
State | Published - Jun 2024 |
Funding
This study was funded in part by the National Psoriasis Foundation and in part by the National Institute of Arthritis and Musculoskeletal and Skin Diseases 5P30AR069589. This study was conducted in Philadelphia, PA. Conceptualization: JMG, ARO, MSG, JSB, DBS, JT; Data Curation: DBS, RF; Formal Analysis: WBS, DBS, AN, RF; Funding Acquisition: JMG; Methodology: JMG, ARO, MSG, JSB, DBS, JT, AMA, NNM, RSB, REK, PJM, ETC; Project Administration: SB, AN; Supervision: JMG, SB Validation: DBS; Writing \u2013 Original Draft Preparation: WBS, JMG; Writing \u2013 Review and Editing: WBS, MSG, JSB, DBS, SB, AN, RF, REK, PJM, ETC, JT, AWA, NNM, RSB, ARO, JMG Funded in part by the National Psoriasis Foundation and in part from NIAMS 5P30AR069589.
Keywords
- Acceptability
- Psoriasis
- Risk
- Screening
- Statin
ASJC Scopus subject areas
- Biochemistry
- Molecular Biology
- Dermatology
- Cell Biology